Newtyn Management as of Sept. 30, 2023
Portfolio Holdings for Newtyn Management
Newtyn Management holds 46 positions in its portfolio as reported in the September 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Cannae Holdings (CNNE) | 13.2 | $54M | 2.9M | 18.64 | |
Iac Com New (IAC) | 11.6 | $47M | 930k | 50.39 | |
PAR Technology Corporation (PAR) | 9.3 | $38M | 983k | 38.54 | |
Merrimack Pharmaceuticals In Com New (MACK) | 5.7 | $23M | 1.9M | 12.33 | |
Ardagh Metal Packaging S A SHS (AMBP) | 5.6 | $23M | 7.2M | 3.13 | |
G-III Apparel (GIII) | 5.0 | $20M | 819k | 24.92 | |
Spectrum Brands Holding (SPB) | 4.8 | $20M | 250k | 78.35 | |
Bristow Group (VTOL) | 4.8 | $20M | 693k | 28.17 | |
Theravance Biopharma (TBPH) | 3.9 | $16M | 1.8M | 8.63 | |
City Office Reit (CIO) | 3.3 | $14M | 3.2M | 4.25 | |
2seventy Bio Common Stock (TSVT) | 3.0 | $12M | 3.1M | 3.92 | |
Garrett Motion (GTX) | 2.6 | $11M | 1.3M | 7.88 | |
Mbia (MBI) | 2.5 | $10M | 1.4M | 7.21 | |
Galapagos Nv Spon Adr (GLPG) | 2.3 | $9.5M | 275k | 34.55 | |
Bv Finl Com New (BVFL) | 2.2 | $8.9M | 879k | 10.08 | |
Cyteir Therapeutics | 1.8 | $7.1M | 2.5M | 2.84 | |
Ni Hldgs (NODK) | 1.5 | $6.0M | 470k | 12.87 | |
Forum Energy Technologies In Note 9.000% 8/0 (Principal) | 1.3 | $5.4M | 5.5M | 0.98 | |
Tillys Cl A (TLYS) | 1.3 | $5.4M | 662k | 8.12 | |
Pfsweb Com New | 1.3 | $5.3M | 712k | 7.44 | |
Phathom Pharmaceuticals (PHAT) | 1.3 | $5.2M | 500k | 10.37 | |
Forum Energy Technologies In (FET) | 1.1 | $4.4M | 183k | 24.02 | |
PG&E Corporation (PCG) | 1.1 | $4.3M | 269k | 16.13 | |
Star Hldgs Shs Ben Int (STHO) | 1.0 | $4.1M | 327k | 12.52 | |
Algoma Stl Group (ASTL) | 1.0 | $4.0M | 591k | 6.80 | |
89bio (ETNB) | 0.8 | $3.1M | 201k | 15.44 | |
Avrobio Ord (AVRO) | 0.8 | $3.1M | 2.0M | 1.54 | |
Wave Life Sciences SHS (WVE) | 0.7 | $2.9M | 510k | 5.75 | |
Kodiak Sciences (KOD) | 0.7 | $2.9M | 1.6M | 1.80 | |
Destination Xl (DXLG) | 0.7 | $2.7M | 600k | 4.48 | |
Orion Office Reit Inc-w/i (ONL) | 0.6 | $2.5M | 475k | 5.21 | |
Olema Pharmaceuticals (OLMA) | 0.5 | $1.9M | 150k | 12.35 | |
Apartment Invt & Mgmt Cl A (AIV) | 0.4 | $1.6M | 232k | 6.80 | |
Adverum Biotechnologies | 0.4 | $1.5M | 1.0M | 1.50 | |
Sensei Biotherapeutics (SNSE) | 0.3 | $1.4M | 1.8M | 0.75 | |
Graphite Bio | 0.3 | $1.3M | 543k | 2.48 | |
Atea Pharmaceuticals (AVIR) | 0.3 | $1.2M | 400k | 3.00 | |
Bolt Biotherapeutics (BOLT) | 0.3 | $1.1M | 1.0M | 1.04 | |
Mersana Therapeutics (MRSN) | 0.2 | $889k | 700k | 1.27 | |
Aligos Therapeutics (ALGS) | 0.2 | $687k | 920k | 0.75 | |
Arca Biopharma (ABIO) | 0.1 | $603k | 300k | 2.01 | |
Black Diamond Therapeutics (BDTX) | 0.1 | $588k | 205k | 2.87 | |
Brilliant Acquisition Corp Right 99/99/9999 | 0.0 | $96k | 457k | 0.21 | |
Arisz Acquisition Corp Right 99/99/9999 | 0.0 | $23k | 250k | 0.09 | |
Leafly Holdings *w Exp 02/04/202 (LFLYW) | 0.0 | $19k | 635k | 0.03 | |
Viveon Health Acquisition Right 12/31/2025 (VHAQR) | 0.0 | $13k | 250k | 0.05 |